Skip to main content
VCbacked
Log inGet Started

Kuehnle Agrosystems

Honolulu, United States

Kuehnle Agrosystems is involved in biotech research and development of plant-based systems for producing biologically active compounds.

$3.0M raised
Mar 2024
Series A
BiotechnologyDeveloper PlatformGeneticsHealth Care

Top Investors

S2G InvestmentsAqua SparkCavallo VenturesHATCH Aquaculture AcceleratorHatch

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kuehnle Agrosystems

How much funding has Kuehnle Agrosystems raised?
Kuehnle Agrosystems has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Who are Kuehnle Agrosystems's investors?
Kuehnle Agrosystems's investors include S2G Investments, Aqua Spark, Cavallo Ventures, HATCH Aquaculture Accelerator, Hatch.
Where is Kuehnle Agrosystems headquartered?
Kuehnle Agrosystems is headquartered in Honolulu, United States.
What does Kuehnle Agrosystems do?
Kuehnle Agrosystems is involved in biotech research and development of plant-based systems for producing biologically active compounds.
What stage is Kuehnle Agrosystems at?
Kuehnle Agrosystems is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kuehnle Agrosystems — Funding & Investors." VCBacked, March 13, 2024, https://www.vcbacked.co/company/kuehnle-agrosystems. Accessed June 5, 2026.
APA
VCBacked. (2024). Kuehnle Agrosystems — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/kuehnle-agrosystems
Wikipedia (cite web)
{{cite web |title=Kuehnle Agrosystems — Funding & Investors |url=https://www.vcbacked.co/company/kuehnle-agrosystems |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong